EUDA Health Holdings Debt to Equity Ratio 2022-2024 | EUDA

Current and historical debt to equity ratio values for EUDA Health Holdings (EUDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. EUDA Health Holdings debt/equity for the three months ending June 30, 2024 was 0.00.
EUDA Health Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $0.01B $-0.01B -1.34
2023-12-31 $0.00B 0.00
2023-03-31 $0.03B $-0.01B -5.29
2022-12-31 $0.00B 0.00
2022-03-31 $0.00B $0.00B 0.00
2021-12-31 $0.01B $0.00B 12.33
2021-10-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.146B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.971B 53.83
Hims & Hers Health (HIMS) United States $11.505B 119.54
Tempus AI (TEM) United States $11.232B 0.00
Inspire Medical Systems (INSP) United States $4.506B 70.41
IRhythm Technologies (IRTC) United States $4.374B 0.00
Privia Health (PRVA) United States $3.041B 208.92
Clover Health Investments (CLOV) United States $1.916B 0.00
Enovis (ENOV) United States $1.889B 10.53
Schrodinger (SDGR) United States $1.744B 0.00
Phreesia (PHR) United States $1.492B 0.00
Azenta (AZTA) United States $1.266B 58.96
Omnicell (OMCL) United States $1.189B 20.98
10x Genomics (TXG) United States $1.055B 0.00
Fulgent Genetics (FLGT) United States $0.565B 0.00
Butterfly Network (BFLY) United States $0.561B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.424B 0.00
TruBridge (TBRG) United States $0.374B 833.33
Claritev (CTEV) United States $0.350B 0.00
Health Catalyst (HCAT) United States $0.293B 0.00
Nyxoah SA (NYXH) Belgium $0.211B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
Pulmonx (LUNG) United States $0.147B 0.00
American Well (AMWL) United States $0.109B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.086B 0.00
CareCloud (CCLD) United States $0.078B 2.97
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.057B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00